Stock search

Ticker or company name

Compare stocks

Market: US

  • ABBVAbbVie

Add stock

Ticker or company

Summary

ABBV
AbbVie
$294,55Down −0,16%
Year: Up +27%
72/100Ratio would consider buying
Open stock page

Traffic light — 10 checks

CheckABBV5 ✓ 3 — 1 ✕
P/E vs its history50,4
P/E vs industry50,4
Forward P/E18,7
Revenue growth, YoY+10,7%
EPS growth, YoY+340,2%
Net margin15,7%
Net debt / EBITDA−0,5
Free cash flow$18,9 bn
Share count over a year0,0%
Cash runwayn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterABBVTTMIndustry medianTTM
P/E TTM ↓50,442,1
Forward P/E ↓18,718,7
PEG ↓3,94,1
P/S TTM ↓7,96,6
EV/EBITDA ↓26,928,2
P/FCF ↓27,626,0

Price, %

  • ABBVn/a

Returns

Best WorstNo mark — in between

PeriodABBV
1 yearn/a
3 yearsn/a
5 yearsn/a
All timen/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

ABBV
Share of “buy”82%
Beat the forecast2 of 4
Average “surprise”−0,1%
Insiders over 12 monthssales $30,8 m

Details are on each stock page.